3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Localized, Operable Non-small Cell Lung Cancer
1
Hodgkin Disease
1
Interventions
Rituximab
3
Cyclophosphamide
3
obinutuzumab
2
fludarabine
2
daratumumab
2
Specimen Handling
2
Prednisone
2
Magnetic Resonance Spectroscopy
2
Immunotherapy, Adoptive
2
Dexamethasone
2
Bortezomib
2
Biopsy
2
Bendamustine Hydrochloride
2
zanubrutinib
1
venetoclax
1
tafasitamab
1
selinexor
1
prednylidene
1
polatuzumab vedotin
1
pegaspargase
1
orelabrutinib
1
nelarabine
1
merphos
1
glofitamab
1
exifone
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
calaspargase pegol
1
auricularum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Lymphoma
×
Neuropsychological Tests
×
Clear all
NCT07558057
2026-04-30
COGNITOX
University of Aarhus
Not yet recruiting
225 enrolled